⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CAMP News

CAMP4 Therapeutics Corporation Common Stock

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01